That's your opinion. My opinion is an antiviral which is active against Covid,even to a mild degree, will be an important part of any treatment regimen for Covid 19.Currently none of the antivirals studied against Covid19 have shown reproducible results in lowering the mortality or complications of Covid19.
It appears we will know the results of the Phase 2 trial sooner than we thought.
Then of course the risk of being long is reduced by the potential of Brilacidin being a pan viral agent, a unique treatment for inflammatory bowel disease as well as a means of reducing the pain and irritation suffered by patients receiving cis platinum and radiation for head and neck cancer.
All of the above are reasons I bought more shares yesterday.
Glta,
Farrell
News 
Market Data 
Discover 
AI
